Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions – Third Meeting
This is the third meeting of the committee of experts and will be conducted virtually. The meeting will include a closed and public session. There will be an opportunity for interested stakeholders to share public comments with the committee on February 7, 2024 at 12:00 p.m. Public comments will provide the committee with additional insight